Market Overview

UPDATE: Benchmark Company Initiates Coverage on Varian Medical Systems with Buy Rating, $88 PT

Share:
Related VAR
Varian Rides on Oncology and Proton Therapy Businesses
Varian Showcases Halcyon System at DEGRO Meet, Stock Up
Delphi Private Advisors LLC Buys Union Pacific Corp, WEC Energy Group Inc, Wells Fargo, Sells ... (GuruFocus)

In a report published Friday, Benchmark Company initiated coverage on Varian Medical Systems (NYSE: VAR) with a Buy rating and $88.00 price target.

Benchmark noted, “We are initiating coverage of Varian Medical Systems, Inc. (VAR) with a Buy rating and a 12-month price target of $88, or 20 times our fiscal 2014 EPS estimate of $4.42. Based on its historical range, we believe VAR should trade in a range of 15 to 20 times future earnings and, given its world-wide leadership in technology, its backlog, and installed base of customers, our target is based at the top of that range.”

Varian Medical Systems closed on Thursday at $67.74.

Latest Ratings for VAR

DateFirmActionFromTo
May 2017Goldman SachsInitiates Coverage OnNeutral
May 2017BTIG ResearchUpgradesNeutralBuy
Feb 2017Aegis CapitalInitiates Coverage OnHold

View More Analyst Ratings for VAR
View the Latest Analyst Ratings

Posted-In: Benchmark CompanyAnalyst Color Initiation Analyst Ratings

 

Related Articles (VAR)

View Comments and Join the Discussion!